Tested Applications
| Positive WB detected in | K-562 cells, HEK-293 cells, HeLa cells, MCF-7 cells, mouse heart tissue, mouse kidney tissue, mouse liver tissue, mouse skeletal muscle tissue, mouse testis tissue, Raji cells |
| Positive IP detected in | mouse kidney tissue |
| Positive IHC detected in | human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10401-1-AP targets RAIDD in WB, IHC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0630 Product name: Recombinant human CRADD protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-199 aa of BC017042 Sequence: MEARDKQVLRSLRLELGAEVLVEGLVLQYLYQEGILTENHIQEINAQTTGLRKTMLLLDILPSRGPKAFDTFLDSLQEFPWVREKLKKAREEAMTDLPAGDRLTGIPSHILNSSPSDRQINQLAQRLGPEWEPMVLSLGLSQTDIYRCKANHPHNVQSQVVEAFIRWRQRFGKQATFQSLHNGLRAVEVDPSLLLHMLE Predict reactive species |
| Full Name | CASP2 and RIPK1 domain containing adaptor with death domain |
| Calculated Molecular Weight | 23 kDa |
| Observed Molecular Weight | 23 kDa |
| GenBank Accession Number | BC017042 |
| Gene Symbol | CRADD |
| Gene ID (NCBI) | 8738 |
| RRID | AB_2085477 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P78560 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
RAIDD, also named as CRADD, is an apoptotic adaptor molecule specific for caspase-2 and FASL/TNF receptor-interacting protein RIP. In the presence of RIP and TRADD, CRADD recruits caspase-2 to the TNFR-1 signalling complex. CRADD interacts with BCL10 through its caspase recruitment domain and suppresses interactions between BCL10 and CARMA1. It is a negative regulator of the CARMA1 signalosome and suppressor of Th1-and Th17-mediated inflammatory responses.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for RAIDD antibody 10401-1-AP | Download protocol |
| IP protocol for RAIDD antibody 10401-1-AP | Download protocol |
| WB protocol for RAIDD antibody 10401-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RAIDD Polyclonal antibody (Cat# 10401-1-AP) has 7 citations published in Cell Metabolism, Nature Cell Biology, Developmental Cell, EMBO Reports, Journal of Biological Chemistry, Journal of Immunology, and Methods in Cell Biology. Research fields include PIDDosome signaling, steatohepatitis, protein quality control, liver development and regeneration, hepatocarcinogenesis, endothelial cell activation, and T lymphocyte cytokine regulation. All citations used Western blot as the application.
| Species | Application | Title |
|---|---|---|
Cell Metab PIDDosome-SCAP crosstalk controls high-fructose-diet-dependent transition from simple steatosis to steatohepatitis
| ||
Nat Cell Biol Caspase-2 is a condensate-mediated deubiquitinase in protein quality control | ||
Dev Cell E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.
| ||
EMBO Rep PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis. | ||
J Biol Chem The Adaptor CRADD/RAIDD Controls Activation of Endothelial Cells by Proinflammatory Stimuli. | ||
J Immunol Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.
|























